SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-01-28
Tx date 2019-01-23 		$ATT
Abattis Bioceuticals Corp. 		Wilson, Cedric Paul
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-150,000 vol 		0
Filed 2018-12-18
Tx date 2018-11-22 		$ATT
Abattis Bioceuticals Corp. 		Wilson, Cedric Paul
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+150,000 vol 		150,000
Filed 2018-12-18
Tx date 2018-10-01 		$ATT
Abattis Bioceuticals Corp. 		Wilson, Cedric Paul
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26
Tx date 2018-05-07 		$ATT
Abattis Bioceuticals Corp. 		McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26
Tx date 2018-11-22 		$ATT
Abattis Bioceuticals Corp. 		McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$13,500
+150,000 vol
$0.09 each 		150,000
Filed 2018-10-23
Tx date 2018-09-28 		$ATT
Abattis Bioceuticals Corp. 		McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$13,500
+100,000 vol
$0.135 each 		100,000
Filed 2018-10-23
Tx date 2018-05-07 		$ATT
Abattis Bioceuticals Corp. 		McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-23
Tx date 2018-05-07 		$ATT
Abattis Bioceuticals Corp. 		McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-23
Tx date 2018-06-21 		$ATT
Abattis Bioceuticals Corp. 		McParland, Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$18,500
+100,000 vol
$0.185 each 		100,000
Filed 2018-09-19
Tx date 2018-09-17 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-30,000
-200,000 vol
$0.15 each 		-65,000
Filed 2018-09-19
Tx date 2018-09-17 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants 		$30,000
+200,000 vol
$0.15 each 		135,000
Filed 2018-08-10
Tx date 2018-06-18 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$684,336
+4,677,625 vol
$0.1463 each 		12,668,322
Filed 2018-08-08
Tx date 2018-04-26 		$ATT
Abattis Bioceuticals Corp. 		Richter, Wolfgang
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-08
Tx date 2018-04-26 		$ATT
Abattis Bioceuticals Corp. 		Richter, Wolfgang
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-08
Tx date 2018-04-26 		$ATT
Abattis Bioceuticals Corp. 		Richter, Wolfgang
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-03
Tx date 2018-08-01 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-35,400
-236,000 vol
$0.15 each 		1,307,250
Filed 2018-06-27
Tx date 2018-06-26 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$545,376
+4,277,465 vol
$0.1275 each 		14,570,776
Filed 2018-06-27
Tx date 2018-06-26 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$146,200
+1,000,000 vol
$0.1462 each 		10,293,311
Filed 2018-06-21
Tx date 2018-06-19 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$-170,000
-1,000,000 vol
$0.17 each 		9,293,311
Filed 2018-06-21
Tx date 2018-06-19 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-500,000 vol 		10,293,311
Filed 2018-06-21
Tx date 2018-06-19 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-1,500,000 vol
Filed 2018-06-19
Tx date 2018-06-19 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-1,500,000 vol 		9,293,311
Filed 2018-03-15
Tx date 2018-03-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$810,000
+3,000,000 vol
$0.27 each 		10,793,311
Filed 2018-03-14
Tx date 2018-03-12 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$7,874
+29,166 vol
$0.27 each 		160,970
Filed 2018-03-14
Tx date 2018-03-12 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$810,000
+3,000,000 vol
$0.27 each 		7,990,697
Filed 2018-03-02
Tx date 2018-02-27 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-3,500,000 vol 		4,990,697
Filed 2018-02-14
Tx date 2018-02-13 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$1,181,250
+4,500,000 vol
$0.2625 each 		5,587,488
Filed 2018-02-14
Tx date 2018-02-13 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$1,706,250
+6,500,000 vol
$0.2625 each 		8,490,697
Filed 2018-01-22
Tx date 2018-01-19 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-53,100
-90,000 vol
$0.59 each 		476,500
Filed 2018-01-22
Tx date 2018-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-53,100
-90,000 vol
$0.59 each 		566,500
Filed 2018-01-18
Tx date 2018-01-16 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-16,750
-25,000 vol
$0.67 each 		656,500
Filed 2018-01-18
Tx date 2018-01-16 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-43,771
-65,000 vol
$0.67 each 		681,500
Filed 2018-01-17
Tx date 2018-01-16 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$122,743
+762,379 vol
$0.161 each 		7,793,311
Filed 2018-01-16
Tx date 2018-01-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,700
-90,000 vol
$0.53 each 		836,500
Filed 2018-01-16
Tx date 2018-01-15 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-53,100
-90,000 vol
$0.59 each 		746,500
Filed 2018-01-16
Tx date 2018-01-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-48,042
-90,000 vol
$0.53 each 		926,500
Filed 2018-01-16
Tx date 2018-01-11 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-18,300
-30,000 vol
$0.61 each 		1,016,500
Filed 2018-01-16
Tx date 2018-01-11 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-36,000
-60,000 vol
$0.60 each 		1,046,500
Filed 2018-01-08
Tx date 2018-01-05 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,060
-4,500 vol
$0.68 each 		1,106,500
Filed 2018-01-08
Tx date 2018-01-05 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-57,652.65
-85,500 vol
$0.67 each 		1,111,000
Filed 2018-01-08
Tx date 2018-01-04 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-64,800
-90,000 vol
$0.72 each 		1,196,500
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-31,500
-50,000 vol
$0.63 each 		42,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-30,500
-50,000 vol
$0.61 each 		92,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-29,500
-50,000 vol
$0.59 each 		142,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-28,500
-50,000 vol
$0.57 each 		192,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-168,000
-300,000 vol
$0.56 each 		242,971
Filed 2018-01-03
Tx date 2018-01-02 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-27,500
-50,000 vol
$0.55 each 		542,971
Filed 2018-01-02
Tx date 2017-12-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,575
-26,500 vol
$0.55 each 		592,971
Filed 2017-12-21
Tx date 2017-12-20 		$ATT
Abattis Bioceuticals Corp. 		Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Options
51 - Exercise of options
-133,333 vol 		66,667
Filed 2017-12-21
Tx date 2017-12-20 		$ATT
Abattis Bioceuticals Corp. 		Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$19,333
+133,333 vol
$0.145 each 		535,889
Filed 2017-12-20
Tx date 2017-12-18 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$20,999
+48,837 vol
$0.43 each 		619,471
Filed 2017-12-20
Tx date 2017-12-18 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$15,749
+36,627 vol
$0.43 each 		7,030,932
Filed 2017-12-20
Tx date 2017-12-18 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$6,299
+14,651 vol
$0.43 each 		131,804
Filed 2017-12-20
Tx date 2017-12-18 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$15,350
+35,698 vol
$0.43 each 		1,990,697
Filed 2017-12-19
Tx date 2017-12-15 		$ATT
Abattis Bioceuticals Corp. 		Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-55,000
-100,000 vol
$0.55 each 		402,556
Filed 2017-12-19
Tx date 2017-12-18 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
-200,000 vol 		135,000
Filed 2017-12-19
Tx date 2017-12-18 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
+200,000 vol 		335,000
Filed 2017-12-18
Tx date 2017-12-15 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-33,000
-50,000 vol
$0.66 each 		570,634
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-18,427.50
-40,500 vol
$0.455 each 		620,634
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-15,250
-50,000 vol
$0.305 each 		661,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-24,500
-50,000 vol
$0.49 each 		711,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-23,500
-50,000 vol
$0.47 each 		761,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-4,370
-9,500 vol
$0.46 each 		811,134
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-16,500
-50,000 vol
$0.33 each 		820,634
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-12,800
-40,000 vol
$0.32 each 		870,634
Filed 2017-12-18
Tx date 2017-12-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-15,750
-50,000 vol
$0.315 each 		910,634
Filed 2017-12-15
Tx date 2017-12-13 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-70,000
-100,000 vol
$0.70 each 		1,543,250
Filed 2017-12-15
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-20,500
-50,000 vol
$0.41 each 		1,643,250
Filed 2017-12-15
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,000
-50,000 vol
$0.46 each 		1,693,250
Filed 2017-12-13
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-30,360
-66,000 vol
$0.46 each 		1,087,488
Filed 2017-12-13
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-48,000
-100,000 vol
$0.48 each 		1,286,500
Filed 2017-12-13
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-27,000
-50,000 vol
$0.54 each 		1,386,500
Filed 2017-12-13
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-50,000
-100,000 vol
$0.50 each 		1,436,500
Filed 2017-12-06
Tx date 2017-12-06 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-1,046,667 vol 		6,994,305
Filed 2017-11-29
Tx date 2017-11-28 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-3,200
-10,000 vol
$0.32 each 		960,634
Filed 2017-11-29
Tx date 2017-11-28 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-15,750
-50,000 vol
$0.315 each 		970,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,000
-50,000 vol
$0.28 each 		1,020,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-24,500
-100,000 vol
$0.245 each 		1,070,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,500
-50,000 vol
$0.29 each 		1,170,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,250
-50,000 vol
$0.285 each 		1,220,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,750
-50,000 vol
$0.275 each 		1,270,634
Filed 2017-11-29
Tx date 2017-11-27 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,250
-50,000 vol
$0.265 each 		1,320,634
Filed 2017-11-27
Tx date 2017-11-24 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,500
-50,000 vol
$0.23 each 		1,370,634
Filed 2017-11-27
Tx date 2017-11-24 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,250
-50,000 vol
$0.225 each 		1,420,634
Filed 2017-11-27
Tx date 2017-11-23 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,250
-50,000 vol
$0.225 each 		1,470,634
Filed 2017-11-27
Tx date 2017-11-22 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,405
-23,500 vol
$0.23 each 		1,520,634
Filed 2017-11-27
Tx date 2017-11-22 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-22,500
-100,000 vol
$0.225 each 		1,544,134
Filed 2017-11-27
Tx date 2017-11-22 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,500
-50,000 vol
$0.23 each 		1,644,134
Filed 2017-11-08
Tx date 2017-11-06 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-18,275
-107,500 vol
$0.17 each 		1,743,250
Filed 2017-11-01
Tx date 2017-10-30 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$7,352
+52,972 vol
$0.1388 each 		1,694,134
Filed 2017-11-01
Tx date 2017-10-30 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$3,151
+22,702 vol
$0.1388 each 		117,153
Filed 2017-11-01
Tx date 2017-10-30 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$7,788
+56,116 vol
$0.1388 each 		1,954,999
Filed 2017-11-01
Tx date 2017-10-03 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
-27,586 vol 		1,898,883
Filed 2017-10-31
Tx date 2017-10-30 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$13,745
+99,099 vol
$0.1387 each 		8,040,972
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2017-09-12
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,504
+96,551 vol
$0.1088 each 		1,641,162
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2017-09-12
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2017-09-12
Tx date 2015-09-16 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-11 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-6,750
-45,000 vol
$0.15 each 		36,159
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2017-09-12
Tx date 2017-05-29 		$ATT
Abattis Bioceuticals Corp. 		Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-11 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
50 - Grant of options 		$145,000
+1,000,000 vol
$0.145 each 		2,885,000
Filed 2017-09-12
Tx date 2017-09-11 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$5,247
+48,275 vol
$0.1087 each 		7,941,873
Filed 2017-09-12
Tx date 2017-09-11 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$14,499
+100,000 vol
$0.145 each 		7,893,598
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		25,000
Filed 2017-09-12
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$3,151
+28,965 vol
$0.1088 each 		94,451
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Options
50 - Grant of options
+1,000,000 vol 		1,000,000
Filed 2017-09-12
Tx date 2017-04-10 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$15,757
+144,827 vol
$0.1088 each 		1,926,469
Filed 2017-08-30
Tx date 2017-08-24 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-200,000 vol 		7,793,598
Filed 2017-08-30
Tx date 2017-08-24 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$23,000
+200,000 vol
$0.115 each 		7,993,598
Filed 2017-08-30
Tx date 2017-08-24 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$5,246
+60,869 vol
$0.0862 each 		7,793,598
Filed 2017-08-23
Tx date 2017-08-21 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,493
+121,739 vol
$0.0862 each 		1,544,611
Filed 2017-08-23
Tx date 2017-08-21 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
46 - Compensation for services 		$6,995
+81,159 vol
$0.0862 each 		81,159
Filed 2017-08-23
Tx date 2015-09-16 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-21 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$3,148
+36,521 vol
$0.0862 each 		65,486
Filed 2017-08-23
Tx date 2017-08-21 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$13,358
+154,968 vol
$0.0862 each 		1,781,642
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$36,250
+250,000 vol
$0.145 each 		1,422,872
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,504
+96,551 vol
$0.1088 each 		1,172,872
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$5,247
+48,275 vol
$0.1087 each 		7,732,729
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$72,500
+500,000 vol
$0.145 each 		7,684,454
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$3,151
+28,965 vol
$0.1088 each 		28,965
Filed 2017-07-17
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Boddy, Christina Lynn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$72,500
+500,000 vol
$0.145 each 		1,626,674
Filed 2017-07-17
Tx date 2017-07-12 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$13,506
+124,137 vol
$0.1088 each 		1,126,674
Filed 2017-06-21
Tx date 2017-06-15 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$-48,000
-300,000 vol
$0.16 each 		1,850,750
Filed 2017-06-21
Tx date 2017-06-16 		$ATT
Abattis Bioceuticals Corp. 		Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Control or Direction)
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		502,556
Filed 2017-06-21
Tx date 2017-05-29 		$ATT
Abattis Bioceuticals Corp. 		Gordon, Peter Vicars
4 - Director of Issuer
Holder: P V Gordon Holdings Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,556
Filed 2017-06-17
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$-92,500
-500,000 vol
$0.185 each 		7,184,454
Filed 2017-06-17
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		7,684,454
Filed 2017-06-15
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		2,150,750
Filed 2017-06-15
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$5,247
+37,837 vol
$0.1387 each 		7,184,454
Filed 2017-06-15
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		1,002,537
Filed 2017-06-15
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,443
+75,675 vol
$0.138 each 		502,537
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$46,250
+250,000 vol
$0.185 each 		1,076,321
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,503
+75,675 vol
$0.1388 each 		826,321
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		1,536,500
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		1,650,750
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each
Filed 2017-06-06
Tx date 2017-04-28 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$15,750
+87,500 vol
$0.18 each 		426,862
Filed 2017-05-25
Tx date 2017-05-19 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-20,500
-100,000 vol
$0.205 each 		169,191
Filed 2017-05-12
Tx date 2017-05-08 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-14,960
-68,000 vol
$0.22 each 		269,191
Filed 2017-05-12
Tx date 2017-05-08 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-16,560
-72,000 vol
$0.23 each 		337,191
Filed 2017-05-05
Tx date 2017-05-02 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-18,000
-300,000 vol
$0.06 each 		150,000
Filed 2017-05-05
Tx date 2017-05-02 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$18,000
+300,000 vol
$0.06 each 		409,191
Filed 2017-05-04
Tx date 2017-05-02 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,500
-100,000 vol
$0.235 each 		109,191
Filed 2017-05-04
Tx date 2017-05-02 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,140
-100,000 vol
$0.2314 each 		209,191
Filed 2017-05-04
Tx date 2017-05-02 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-12,750
-50,000 vol
$0.255 each 		309,191
Filed 2017-05-04
Tx date 2017-05-02 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-12,500
-50,000 vol
$0.25 each 		359,191
Filed 2017-04-26
Tx date 2017-04-20 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-27,230
-100,000 vol
$0.2723 each 		409,191
Filed 2017-04-26
Tx date 2017-04-06 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,125
-25,000 vol
$0.205 each 		509,191
Filed 2017-04-26
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-30,750
-150,000 vol
$0.205 each 		534,191
Filed 2017-04-26
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-15,375
-75,000 vol
$0.205 each 		684,191
Filed 2017-04-26
Tx date 2017-04-04 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-10,250
-50,000 vol
$0.205 each 		759,191
Filed 2017-04-26
Tx date 2017-04-04 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-10,370
-50,000 vol
$0.2074 each 		809,191
Filed 2017-04-26
Tx date 2017-04-04 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-86.00
-430 vol
$0.20 each 		859,191
Filed 2017-04-26
Tx date 2017-04-03 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-8,500
-50,000 vol
$0.17 each 		859,621
Filed 2017-04-26
Tx date 2017-04-03 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-12,862.50
-73,500 vol
$0.175 each 		909,621
Filed 2017-04-26
Tx date 2017-04-03 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,250
-50,000 vol
$0.185 each 		983,121
Filed 2017-04-26
Tx date 2017-04-03 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,770
-26,500 vol
$0.18 each 		1,033,121
Filed 2017-04-25
Tx date 2012-08-21 		$ATT
Abattis Bioceuticals Corp. 		Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+50,000 vol
Filed 2017-04-25
Tx date 2012-08-21 		$ATT
Abattis Bioceuticals Corp. 		Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+50,000 vol
Filed 2017-04-25
Tx date 2017-04-20 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
-65,000 vol 		135,000
Filed 2017-04-25
Tx date 2015-03-11 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
+200,000 vol 		200,000
Filed 2017-04-25
Tx date 2017-04-20 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$117,966
+669,504 vol
$0.1762 each 		7,146,617
Filed 2017-04-25
Tx date 2015-03-17 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$26,000
+200,000 vol
$0.13 each 		1,053,488
Filed 2017-04-25
Tx date 2017-04-20 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
+339,362 vol 		339,362
Filed 2017-04-25
Tx date 2017-04-10 		$ATT
Abattis Bioceuticals Corp. 		Abenante, Robert
5 - Senior Officer of Issuer
Holder: 1053345 B.C. Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-17
Tx date 2017-04-13 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,315
-73,500 vol
$0.29 each 		1,036,500
Filed 2017-04-16
Tx date 2017-04-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$80,250
+535,000 vol
$0.15 each 		6,477,113
Filed 2017-04-15
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$93,000
+600,000 vol
$0.155 each 		1,150,750
Filed 2017-04-15
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each
Filed 2017-04-15
Tx date 2017-03-30 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,675
-45,000 vol
$0.215 each 		705,750
Filed 2017-04-15
Tx date 2017-03-30 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,450
-45,000 vol
$0.21 each
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each 		680,646
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each 		1,110,000
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each 		1,050,750
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Control or Direction)
Common Shares
46 - Compensation for services 		$10,500
+70,000 vol
$0.15 each 		750,646
Filed 2017-04-05
Tx date 2012-08-21 		$ATT
Abattis Bioceuticals Corp. 		Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$20,000
+250,000 vol
$0.08 each 		300,000
Filed 2017-04-03
Tx date 2017-03-31 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-31,000
-155,000 vol
$0.20 each 		550,750
Filed 2017-04-03
Tx date 2017-03-30 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,450
-45,000 vol
$0.21 each 		705,750
Filed 2017-04-03
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-6,900
-60,000 vol
$0.115 each 		750,750
Filed 2017-04-03
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$90,000
+750,000 vol
$0.12 each 		1,059,621
Filed 2017-03-31
Tx date 2017-03-30 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-17,550
-90,000 vol
$0.195 each 		610,000
Filed 2017-03-28
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$90,000
+750,000 vol
$0.12 each 		868,400
Filed 2017-03-27
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$60,000
+500,000 vol
$0.12 each 		700,000
Filed 2017-03-27
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,300
-60,000 vol
$0.155 each 		60,750
Filed 2017-03-27
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$90,000
+750,000 vol
$0.12 each 		810,750
Filed 2017-03-27
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$60,000
+500,000 vol
$0.12 each 		892,687
Filed 2017-03-15
Tx date 2017-03-10 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
51 - Exercise of options 		$42,000
+700,000 vol
$0.06 each 		1,750,000
Filed 2017-03-15
Tx date 2017-03-10 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
51 - Exercise of options 		$-42,000
-700,000 vol
$0.06 each 		1,050,000
Filed 2017-03-15
Tx date 2017-03-13 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$10,504
+90,322 vol
$0.1163 each 		5,942,113
Filed 2017-03-15
Tx date 2017-03-10 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,175
-85,000 vol
$0.155 each 		5,851,791
Filed 2017-03-15
Tx date 2017-03-10 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-30,000
-200,000 vol
$0.15 each 		5,936,791
Filed 2017-03-14
Tx date 2017-03-13 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$21,009
+180,646 vol
$0.1163 each 		180,646
Filed 2017-03-14
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Holder: Efilcon Consulting Tech Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-06
Tx date 2017-03-03 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-26,021.325
-157,705 vol
$0.165 each 		392,687
Filed 2017-01-27
Tx date 2017-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+200,000 vol 		200,000
Filed 2017-01-27
Tx date 2017-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-14,000
-200,000 vol
$0.07 each 		0
Filed 2017-01-27
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
99 - Correction of information
+200,000 vol 		400,000
Filed 2017-01-27
Tx date 2017-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$40,000,000,000
+200,000 vol
$200,000 each 		200,000
Filed 2017-01-26
Tx date 2017-01-23 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Warrants
54 - Exercise of warrants 		$21,000
+300,000 vol
$0.07 each 		555,556
Filed 2017-01-26
Tx date 2017-01-23 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Warrants
54 - Exercise of warrants 		$-21,000
-300,000 vol
$0.07 each 		255,556
Filed 2017-01-26
Tx date 2017-01-23 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$5,237
+51,852 vol
$0.101 each 		6,136,791
Filed 2017-01-23
Tx date 2017-01-17 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$10,505
+103,704 vol
$0.1013 each 		550,392
Filed 2017-01-18
Tx date 2017-01-09 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-28,000
-200,000 vol
$0.14 each 		0
Filed 2017-01-16
Tx date 2017-01-13 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,520
-18,000 vol
$0.14 each 		446,688
Filed 2017-01-15
Tx date 2017-01-09 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
+200,000 vol 		0
Filed 2017-01-15
Tx date 2017-01-09 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
-200,000 vol 		-200,000
Filed 2017-01-15
Tx date 2017-01-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-28,000
-200,000 vol
$0.14 each 		953,488
Filed 2017-01-15
Tx date 2017-01-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,000
+200,000 vol
$0.09 each 		1,153,488
Filed 2017-01-12
Tx date 2017-01-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,100
-165,000 vol
$0.14 each 		464,688
Filed 2017-01-09
Tx date 2016-08-02 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
36 - Conversion or exchange 		$46,259
+925,186 vol
$0.05 each 		4,987,343
Filed 2016-12-22
Tx date 2016-12-19 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-18,450
-123,000 vol
$0.15 each 		120,750
Filed 2016-12-19
Tx date 2016-12-12 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$5,249
+53,846 vol
$0.0975 each 		5,159,753
Filed 2016-12-16
Tx date 2016-12-12 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$5,813
+59,621 vol
$0.0975 each 		309,621
Filed 2016-12-14
Tx date 2016-12-12 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$5,249
+53,846 vol
$0.0975 each 		629,688
Filed 2016-12-04
Tx date 2016-11-25 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-14,500
-100,000 vol
$0.145 each 		200,000
Filed 2016-11-22
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$5,250
+43,750 vol
$0.12 each 		575,842
Filed 2016-11-22
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Xie, Shuang
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		532,092
Filed 2016-11-18
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$5,250
+43,750 vol
$0.12 each 		5,105,907
Filed 2016-11-17
Tx date 2016-11-15 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$14,000
+200,000 vol
$0.07 each 		300,000
Filed 2016-11-17
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+100,000 vol 		100,000
Filed 2016-11-17
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-17
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+43,750 vol 		243,750
Filed 2016-11-17
Tx date 2016-11-15 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-14,000
-200,000 vol
$0.07 each 		0
Filed 2016-11-07
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		200,000
Filed 2016-10-24
Tx date 2016-10-14 		$ATT
Abattis Bioceuticals Corp. 		Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$45,000
+250,000 vol
$0.18 each 		925,000
Filed 2016-10-24
Tx date 2016-10-14 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$45,000
+250,000 vol
$0.18 each 		250,000
Filed 2016-10-24
Tx date 2016-10-14 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
50 - Grant of options
+1,750,000 vol 		1,750,000
Filed 2016-10-24
Tx date 2016-10-14 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$117,800
+950,000 vol
$0.124 each 		5,062,157
Filed 2016-10-24
Tx date 2016-10-14 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$3,100
+25,000 vol
$0.124 each 		4,112,157
Filed 2016-10-24
Tx date 2016-09-20 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$1,405
+25,000 vol
$0.0562 each 		4,087,157
Filed 2016-10-24
Tx date 2016-08-02 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$61,019
+1,220,391 vol
$0.05 each 		4,062,157
Filed 2016-10-24
Tx date 2016-07-31 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$875.00
+25,000 vol
$0.035 each 		2,841,766
Filed 2016-10-24
Tx date 2016-06-30 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$875.00
+25,000 vol
$0.035 each 		2,816,766
Filed 2016-10-24
Tx date 2015-09-16 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-25
Tx date 2016-06-30 		$ATT
Abattis Bioceuticals Corp. 		Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$5,416
+135,417 vol
$0.04 each 		545,337
Filed 2016-06-15
Tx date 2016-06-15 		$ATT
Abattis Bioceuticals Corp. 		Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$5,416
+108,333 vol
$0.05 each 		409,920
Filed 2016-06-06
Tx date 2016-05-24 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,500
+100,000 vol
$0.045 each 		953,488
Filed 2016-06-01
Tx date 2016-05-31 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$1,250
+25,000 vol
$0.05 each 		2,791,766
Filed 2016-05-31
Tx date 2016-05-31 		$ATT
Abattis Bioceuticals Corp. 		Amin Shanjani, Maryam
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$500.00
+10,000 vol
$0.05 each 		280,000
Filed 2016-05-27
Tx date 2016-05-19 		$ATT
Abattis Bioceuticals Corp. 		Amin Shanjani, Maryam
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		270,000
Filed 2016-05-09
Tx date 2016-05-03 		$ATT
Abattis Bioceuticals Corp. 		Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$15,079
+301,587 vol
$0.05 each 		301,587
Filed 2016-05-09
Tx date 2016-04-18 		$ATT
Abattis Bioceuticals Corp. 		Yung, Michael David
5 - Senior Officer of Issuer
Holder: 1072915 BC LTD (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-06
Tx date 2016-05-03 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,000
+100,000 vol
$0.05 each 		200,000
Filed 2016-05-06
Tx date 2016-05-03 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$1,250
+25,000 vol
$0.05 each 		2,766,766
Filed 2016-05-06
Tx date 2016-05-03 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,000
+200,000 vol
$0.05 each 		250,000
Filed 2016-05-06
Tx date 2014-09-16 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2016-04-13
Tx date 2015-11-16 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,000
+100,000 vol
$0.09 each 		100,000
Filed 2016-04-13
Tx date 2015-09-16 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-13
Tx date 2015-11-02 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$4,500
+50,000 vol
$0.09 each 		450,000
Filed 2016-04-13
Tx date 2015-08-20 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$18,000
+300,000 vol
$0.06 each 		400,000
Filed 2016-04-13
Tx date 2014-09-17 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,000
+100,000 vol
$0.33 each 		100,000
Filed 2016-04-13
Tx date 2014-09-16 		$ATT
Abattis Bioceuticals Corp. 		Dancosse, Guy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-08
Tx date 2016-04-08 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$165.00
+3,000 vol
$0.055 each 		2,741,766
Filed 2016-04-08
Tx date 2016-04-07 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$9,460
+172,000 vol
$0.055 each 		2,738,766
Filed 2016-04-05
Tx date 2016-04-01 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$1,500
+25,000 vol
$0.06 each 		2,566,766
Filed 2016-03-04
Tx date 2016-02-29 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services
+25,000 vol 		2,541,766
Filed 2015-11-12
Tx date 2015-08-19 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$9,000
+100,000 vol
$0.09 each 		100,000
Filed 2015-11-12
Tx date 2014-06-18 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-12
Tx date 2015-08-19 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$9,000
+100,000 vol
$0.09 each
Filed 2015-11-12
Tx date 2015-08-19 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$9,000
+100,000 vol
$0.09 each
Filed 2015-11-12
Tx date 2015-03-19 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus 		$13,846
+76,923 vol
$0.18 each 		76,923
Filed 2015-11-12
Tx date 2014-06-18 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-12
Tx date 2015-08-19 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$5,000
+100,000 vol
$0.05 each 		100,000
Filed 2015-11-12
Tx date 2014-06-18 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Holder: Manewagi Technologies Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-12
Tx date 2015-11-12 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$33,923
+376,923 vol
$0.09 each 		376,923
Filed 2015-11-12
Tx date 2015-11-09 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-30,153.84
-376,923 vol
$0.08 each 		0
Filed 2015-11-12
Tx date 2015-03-19 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$9,999
+76,923 vol
$0.13 each 		376,923
Filed 2015-08-25
Tx date 2015-08-24 		$ATT
Abattis Bioceuticals Corp. 		Minshew, Brazos Arthur Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options 		$30,000
+500,000 vol
$0.06 each 		500,000
Filed 2015-08-25
Tx date 2014-07-01 		$ATT
Abattis Bioceuticals Corp. 		Minshew, Brazos Arthur Glenn
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-25
Tx date 2015-08-20 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$42,000
+700,000 vol
$0.06 each 		700,000
Filed 2015-08-25
Tx date 2014-06-18 		$ATT
Abattis Bioceuticals Corp. 		Fleming, William James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-24
Tx date 2015-08-20 		$ATT
Abattis Bioceuticals Corp. 		Sorocco, Douglas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$18,000
+300,000 vol
$0.06 each 		675,000
Filed 2015-08-24
Tx date 2015-08-20 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Options
50 - Grant of options 		$42,000
+700,000 vol
$0.06 each 		1,885,000
Filed 2015-08-24
Tx date 2015-08-18 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$1,750
+25,000 vol
$0.07 each 		2,516,766
Filed 2015-07-20
Tx date 2015-07-03 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$7,893
+98,666 vol
$0.08 each 		2,491,766
Filed 2015-07-20
Tx date 2015-07-03 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$1,625
+25,000 vol
$0.065 each 		2,393,100
Filed 2015-07-20
Tx date 2015-06-03 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$2,750
+25,000 vol
$0.11 each 		2,368,100
Filed 2015-07-20
Tx date 2015-06-03 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$27,500
+250,000 vol
$0.11 each
Filed 2015-07-20
Tx date 2015-03-04 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$34,375
+196,429 vol
$0.175 each 		2,172,985
Filed 2015-07-20
Tx date 2015-05-06 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$14,000
+116,667 vol
$0.12 each 		2,343,100
Filed 2015-06-03
Tx date 2015-06-03 		$ATT
Abattis Bioceuticals Corp. 		David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
Common Shares
46 - Compensation for services 		$27,500
+250,000 vol
$0.11 each 		2,280,004